Tian'an Pharmaceutical CO., Ltd. - Notification that Annual Report will be submitted late (NT 10-K)
April 01 2008 - 12:03PM
Edgar (US Regulatory)
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SEC File Number: None
CUSIP Number 88631V103
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR
For Period Ended: December 31, 2007
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates: N/A
Part I - Registrant Information
Full Name of Registrant: Tian'an Pharmaceutical Co., Ltd.
Former Name if Applicable: N/A
Address of Principal Executive Office (Street and Number)
Level 11, International Trade Centre
No.196 Xiaozhai East Road
City, State and Zip Code
Xi'an, China
1
Part II - Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.
(Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, or transition report or
portion thereof will be filed on or before the fifteenth calendar day following
the prescribed due date; or the subject quarterly report or transition report on
Form l0-Q or portion thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
Part III - Narrative
State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K,
10-Q, or N-SAR, or the transition report or portion thereof could not be filed
within the prescribed time period.
The Company did not complete its financial statements for the year ended
December 31, 2007 in sufficient time to allow the filing of the annual report on
Form 10-KSB by March 31, 2008. As a result, additional time is needed to file
the report.
Part IV - Other Information
(1) Name and telephone number of person to contact in regard to this
notification
William T. Hart (303) 839-0061
(Name) (Area Code) (Telephone Number)
2
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding l2 months (or
for such shorter period that the registrant was required to file such
reports) been filed? If answer
is no, identify report(s). [X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included
in the subject report or portion thereof? [ ] Yes [X] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
New Taohuayuan Culture Tourism Co., Ltd
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 31, 2008 By /s/ William T. Hart
-----------------------------------
William T. Hart
Hart & Trinen, LLP
1624 Washington Street
Denver, Colorado 80203
Phone: (303) 839-0061
|
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
Tian An Pharmaceutical (PK) (USOTC:TNPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tian An Pharmaceutical (PK) (USOTC:TNPH)
Historical Stock Chart
From Jul 2023 to Jul 2024